bk virus nephropathy
Showing 1 - 5 of 5
BK Virus Nephropathy Trial in Adelaide (AntiBKV, Placebo)
Active, not recruiting
- BK Virus Nephropathy
- AntiBKV
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jan 3, 2023
BK Virus Nephropathy, BK Virus Infection Trial in United States (Posoleucel (formerly known as ALVR105) cells, Placebo (visually
Active, not recruiting
- BK Virus Nephropathy
- BK Virus Infection
- Posoleucel (formerly known as ALVR105) cells
- Placebo (visually identical to Posoleucel)
-
Phoenix, Arizona
- +37 more
May 10, 2022
Renal Pretransplant Serology for BK Virus on Risk of
Recruiting
- BK Virus Nephropathy
- +2 more
- serum withdrawal
-
Amiens, FranceCHU Amiens
Jul 20, 2021
BK Virus Post-Kidney Transplant: New Practice Versus Traditional
Withdrawn
- BK Virus Infection
- BK Virus Nephropathy
- New Protocol - BK viremia or BK virus nephropathy
- Standard Protocol - BK viremia or BK virus nephropathy
-
Loma Linda, CaliforniaLoma Linda University Medical Center
Oct 1, 2020
BK Virus Nephropathy Trial (MAU868, Placebo)
Withdrawn
- BK Virus Nephropathy
- MAU868
- Placebo
- (no location specified)
Dec 11, 2018